<DOC>
	<DOCNO>NCT01274923</DOCNO>
	<brief_summary>This study aim evaluate effect shockwave therapy erectile dysfunction patient respond PDE5i therapy sham control randomize double blind manner .</brief_summary>
	<brief_title>Double Blind Placebo Controlled Study Effect Extracorporal Shock Wave Therapy Erectile Dysfunction PDE5i Responders</brief_title>
	<detailed_description>This study aim evaluate effect 12-session low intensity shockwave therapy protocol patient erectile dysfunction . On screen patient undergo evaluation thorough medical history questionnaire evaluation sexual function . A one-month active treatment PDE5i provide follow re-evaluation use questionnaire . Then another one-month period without PDE5i medication ( washout period ) do finally follow visit evaluation include questionnaire fit inclusion- additional objective evaluation endothelial function use Flow mediate dilatation technique penile blood flow measurement doppler ultrasound Penis perform . At end screen pahse first shock wave session perform . Altogether 12 treatment session perform - 6 treatment twice week follow 3 week no-treatment interval 6 treatment twice week . Follow-up include evaluation first treatment visit perform one month end treatment</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<criteria>ED 6 month Rigidity score ≥ 3 PDE5i therapy SHIM ≤21 PDE5i therapy Non hormonal , neurological psychological pathology Stable heterosexual relationship 3 month Prior prostatectomy surgery Any unstable medical , psychiatric , spinal cord injury penile anatomical abnormality Clinically significant chronic hematological disease Antiandrogens , oral injectable androgen Radiotherapy pelvic region</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Erectile dysfunction</keyword>
	<keyword>Low Intensity Shock Wave</keyword>
</DOC>